InspireMD, Inc. (NSPR)
USD 2.53
(-5.87%)
USD 2.53
(-5.87%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 6.2 Million USD | 20.0% |
| 2022 | 5.17 Million USD | 15.04% |
| 2021 | 4.49 Million USD | 80.89% |
| 2020 | 2.48 Million USD | -33.22% |
| 2019 | 3.72 Million USD | 3.33% |
| 2018 | 3.6 Million USD | 30.42% |
| 2017 | 2.76 Million USD | 45.78% |
| 2016 | 1.89 Million USD | -18.01% |
| 2015 | 2.31 Million USD | -18.03% |
| 2014 | 2.81 Million USD | -42.17% |
| 2013 | 4.87 Million USD | -8.9% |
| 2012 | 5.34 Million USD | -10.91% |
| 2011 | 6 Million USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 1.73 Million USD | 15.09% |
| 2024 Q1 | 1.51 Million USD | -14.2% |
| 2023 Q1 | 1.23 Million USD | 20.76% |
| 2023 Q3 | 1.55 Million USD | -5.64% |
| 2023 Q4 | 1.76 Million USD | 13.17% |
| 2023 FY | 6.2 Million USD | 20.0% |
| 2023 Q2 | 1.64 Million USD | 33.09% |
| 2022 Q4 | 1.02 Million USD | -28.3% |
| 2022 Q1 | 1.18 Million USD | -14.28% |
| 2022 FY | 5.17 Million USD | 15.04% |
| 2022 Q2 | 1.53 Million USD | 29.42% |
| 2022 Q3 | 1.43 Million USD | -6.53% |
| 2021 Q2 | 1.03 Million USD | 3.18% |
| 2021 Q4 | 1.38 Million USD | 28.85% |
| 2021 FY | 4.49 Million USD | 80.89% |
| 2021 Q1 | 1 Million USD | 536.71% |
| 2021 Q3 | 1.07 Million USD | 3.18% |
| 2020 Q3 | 980 Thousand USD | 213.1% |
| 2020 FY | 2.48 Million USD | -33.22% |
| 2020 Q1 | 1.03 Million USD | 2.07% |
| 2020 Q2 | 313 Thousand USD | -69.73% |
| 2020 Q4 | 158 Thousand USD | -83.88% |
| 2019 Q3 | 939 Thousand USD | -30.65% |
| 2019 Q2 | 1.35 Million USD | 226.27% |
| 2019 Q1 | 415 Thousand USD | -49.51% |
| 2019 FY | 3.72 Million USD | 3.33% |
| 2019 Q4 | 1.01 Million USD | 7.88% |
| 2018 Q2 | 1 Million USD | -0.4% |
| 2018 Q4 | 822 Thousand USD | 6.89% |
| 2018 Q3 | 769 Thousand USD | -23.33% |
| 2018 FY | 3.6 Million USD | 30.42% |
| 2018 Q1 | 1 Million USD | 20.89% |
| 2017 Q3 | 718 Thousand USD | 12.19% |
| 2017 Q4 | 833 Thousand USD | 16.02% |
| 2017 FY | 2.76 Million USD | 45.78% |
| 2017 Q1 | 569 Thousand USD | 76.71% |
| 2017 Q2 | 640 Thousand USD | 12.48% |
| 2016 Q4 | 322 Thousand USD | -31.34% |
| 2016 FY | 1.89 Million USD | -18.01% |
| 2016 Q1 | 563 Thousand USD | 9.11% |
| 2016 Q3 | 469 Thousand USD | -13.15% |
| 2016 Q2 | 540 Thousand USD | -4.09% |
| 2015 FY | 2.31 Million USD | -18.03% |
| 2015 Q3 | 632 Thousand USD | -7.74% |
| 2015 Q4 | 516 Thousand USD | -18.35% |
| 2015 Q2 | 685 Thousand USD | 43.61% |
| 2015 Q1 | 477 Thousand USD | -45.17% |
| 2014 Q2 | 193 Thousand USD | -86.98% |
| 2014 Q3 | 273 Thousand USD | 41.45% |
| 2014 FY | 2.81 Million USD | -42.17% |
| 2014 Q1 | 1.48 Million USD | 0.0% |
| 2014 Q4 | 870 Thousand USD | 218.68% |
| 2013 Q2 | 1.5 Million USD | -0.92% |
| 2013 Q1 | 1.51 Million USD | 12.15% |
| 2013 FY | 4.87 Million USD | -8.9% |
| 2013 Q4 | - USD | -100.0% |
| 2013 Q3 | 1.55 Million USD | 3.47% |
| 2012 Q2 | 933 Thousand USD | -18.01% |
| 2012 Q1 | 1.13 Million USD | -11.92% |
| 2012 FY | 5.34 Million USD | -10.91% |
| 2012 Q4 | 1.35 Million USD | 165.23% |
| 2012 Q3 | 509 Thousand USD | -45.44% |
| 2011 Q1 | 1.68 Million USD | 0.0% |
| 2011 FY | 6 Million USD | 0.0% |
| 2011 Q4 | 1.29 Million USD | -34.94% |
| 2011 Q3 | 1.98 Million USD | 90.96% |
| 2011 Q2 | 1.04 Million USD | -38.32% |
| 2010 Q4 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | 48.545% |
| BrainsWay Ltd. | 31.78 Million USD | 80.478% |
| Cerus Corporation | 156.36 Million USD | 96.032% |
| Envoy Medical, Inc. | 316 Thousand USD | -1863.608% |
| electroCore, Inc. | 16.03 Million USD | 61.291% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -863.509% |
| IceCure Medical Ltd | 3.22 Million USD | -92.165% |
| Inogen, Inc. | 315.66 Million USD | 98.034% |
| OrthoPediatrics Corp. | 148.73 Million USD | 95.828% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -155.56% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -1600.005% |
| MaxCyte, Inc. | 41.28 Million USD | 84.971% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -217.807% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -5502.81% |
| Orthofix Medical Inc. | 746.64 Million USD | 99.169% |
| PAVmed Inc | 2.45 Million USD | -153.059% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | 72.445% |
| RxSight, Inc. | 89.07 Million USD | 93.034% |
| Sight Sciences, Inc. | 81.05 Million USD | 92.345% |
| SI-BONE, Inc. | 138.88 Million USD | 95.532% |
| TELA Bio, Inc. | 58.45 Million USD | 89.385% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 96.684% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | 55.039% |
| Acutus Medical, Inc. | 7.16 Million USD | 13.386% |
| Talis Biomedical Corporation | 412 Thousand USD | -1406.068% |
| Spectral AI, Inc. | 18.05 Million USD | 65.635% |
| Nano-X Imaging Ltd. | 9.9 Million USD | 37.355% |
| CVRx, Inc. | 39.29 Million USD | 84.209% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -540.545% |
| Bioventus Inc. | 512.34 Million USD | 98.789% |
| Venus Concept Inc. | 76.35 Million USD | 91.873% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | 66.479% |
| LivaNova PLC | 1.15 Billion USD | 99.462% |
| 908 Devices Inc. | 50.22 Million USD | 87.647% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 98.713% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -7953.839% |
| NeuroPace, Inc. | 65.42 Million USD | 90.515% |
| LENSAR, Inc. | 42.16 Million USD | 85.284% |
| Apyx Medical Corporation | 52.34 Million USD | 88.147% |
| Cutera, Inc. | 212.36 Million USD | 97.078% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | 81.399% |
| BioSig Technologies, Inc. | 18 Thousand USD | -34372.222% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 96.277% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | 74.097% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 99.597% |
| Axonics, Inc. | 366.37 Million USD | 98.306% |
| Outset Medical, Inc. | 130.37 Million USD | 95.241% |
| IRIDEX Corporation | 51.86 Million USD | 88.037% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | 95.444% |
| IRadimed Corporation | 65.56 Million USD | 90.536% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -427.636% |
| INVO Bioscience, Inc. | 3.02 Million USD | -105.424% |
| Telesis Bio, Inc. | 27.5 Million USD | 77.444% |
| Viemed Healthcare, Inc. | 183 Million USD | 96.609% |
| Varex Imaging Corporation | 811 Million USD | 99.235% |
| Quipt Home Medical Corp. | 221.74 Million USD | 97.202% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | 90.965% |
| Dynatronics Corporation | 32.53 Million USD | 80.928% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | 28.497% |
| Semler Scientific, Inc. | 68.18 Million USD | 90.9% |
| InMode Ltd. | 492.04 Million USD | 98.739% |
| Bruker Corporation | 2.96 Billion USD | 99.791% |
| Cytosorbents Corporation | 36.34 Million USD | 82.93% |
| DexCom, Inc. | 3.62 Billion USD | 99.829% |
| Align Technology, Inc. | 3.86 Billion USD | 99.839% |
| Viveve Medical, Inc. | 6.42 Million USD | 3.439% |
| ZimVie Inc. | 457.43 Million USD | 98.644% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 96.785% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -5502.81% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 99.17% |
| Profound Medical Corp. | 7.33 Million USD | 15.36% |
| Insulet Corporation | 1.69 Billion USD | 99.634% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | 95.078% |
| iCAD, Inc. | 17.31 Million USD | 64.17% |
| Nuwellis, Inc. | 8.86 Million USD | 29.998% |
| Biotricity, Inc. | 12.06 Million USD | 48.563% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 98.741% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| PAVmed Inc. | 2.45 Million USD | -153.059% |
| BIOLASE, Inc. | 49.16 Million USD | 87.379% |
| Beyond Air, Inc. | 1.15 Million USD | -435.375% |
| FONAR Corporation | 102.88 Million USD | 93.969% |
| AxoGen, Inc. | 159.01 Million USD | 96.098% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 97.739% |
| Inari Medical, Inc. | 493.63 Million USD | 98.743% |
| UFP Technologies, Inc. | 400.07 Million USD | 98.449% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -33260.215% |
| Tenon Medical, Inc. | 2.92 Million USD | -111.919% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | 8.911% |
| AdaptHealth Corp. | 3.2 Billion USD | 99.806% |
| Sintx Technologies, Inc. | 2.62 Million USD | -136.201% |
| NanoVibronix, Inc. | 2.28 Million USD | -171.792% |
| Quanterix Corporation | 122.36 Million USD | 94.929% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | 74.575% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 96.906% |
| TransMedics Group, Inc. | 241.62 Million USD | 97.432% |
| ReWalk Robotics Ltd. | 13.85 Million USD | 55.211% |
| NeuroMetrix, Inc. | 5.9 Million USD | -5.144% |
| Hyperfine, Inc. | 11.03 Million USD | 43.755% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 96.243% |
| Biomerica, Inc. | 5.41 Million USD | -14.589% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | 87.728% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 96.497% |